newsfilter
← Latest News
Business Wire·

Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program

Delcath Systems, Inc. (NASDAQ:DCTH), ("Delcath") an interventional oncology company focused on the treatment of primary and metastatic cancers to the liver, today announced that its Board of Directors has authorized a